Related Experiment Video
Updated: Jun 16, 2025
An Electroporation Method to Transform Rickettsia spp. with a Fluorescent Protein-Expressing Shuttle Vector in Tick Cell Lines
Published on: October 11, 2022
Inhibitors of Rickettsia prowazekii methionine aminopeptidase 1 identified from the Pandemic Response Box
Ishpriya Sharma1, Drashti Daraji1, James R Horn1
1Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115, United States.
Abstract:
Methionine aminopeptidase (MetAp) enzymes catalyze the post-translational removal of the initiator methionine residue in newly synthesized proteins, a process that is often essential in the maturation of proteins. Consequently, these enzymes serve as important targets for drug development. Rickettsia prowazekii (Rp) is an obligate coccobacillus and the causative agent of the louse-borne epidemic typhus and despite adequate treatment causes a latent infection. This research aimed to identify potential anti-rickettsial agents by screening 400 compounds from the MMV Pandemic Response Box against RpMetAp1. Overall, 19 compounds were identified that possessed IC50 values from 10 µM to 340 nM. The most potent inhibitor was MMV 1580488 (17), which was observed to have an IC50 of 340 nM. The selected hits serve as chemical leads that can be used for the development of potent inhibitors of the RpMetAp1 enzyme.
Insights
Researchers screened 400 compounds to find inhibitors for Rickettsia prowazekii methionine aminopeptidase (RpMetAp1). Nineteen compounds showed activity, with one potent inhibitor identified as a potential lead for anti-rickettsial drug development.
Area of Science:
- Biochemistry
- Drug Discovery
- Microbiology
Background:
- Methionine aminopeptidase (MetAp) enzymes are crucial for protein maturation, making them significant drug targets.
- Rickettsia prowazekii (Rp) causes epidemic typhus and can establish latent infections, necessitating novel therapeutic strategies.
Purpose of the Study:
- To identify novel anti-rickettsial agents by screening for inhibitors of Rickettsia prowazekii methionine aminopeptidase 1 (RpMetAp1).
- To discover chemical leads for developing new treatments against Rickettsia prowazekii infections.
Main Methods:
- A library of 400 compounds from the MMV Pandemic Response Box was screened against purified RpMetAp1.
- Inhibitory activity was quantified by determining IC50 values for active compounds.
Main Results:
- Nineteen compounds exhibited inhibitory activity against RpMetAp1, with IC50 values ranging from 340 nM to 10 µM.
- Compound MMV 1580488 (17) demonstrated the highest potency with an IC50 of 340 nM.
Conclusions:
- The identified compounds represent promising chemical leads for the development of novel RpMetAp1 inhibitors.
- This research provides a foundation for developing new therapeutic interventions against Rickettsia prowazekii.
More Related Videos
10:46A Calcium Bioluminescence Assay for Functional Analysis of Mosquito Aedes aegypti and Tick Rhipicephalus microplus G Protein-coupled Receptors
Published on: April 20, 2011
12:03Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
Published on: July 23, 2017
